Position in BIOA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,091,113
New position
Shares Held
62,385
first reported quarter
Ownership
0.136%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $374,044,345 across 37 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
5,284,773 | $130,058,261 | |
| 2 | VTRS |
Viatris Inc
|
3,165,469 | $50,267,647 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,105,005 | $37,437,568 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
185,545 | $31,271,754 | |
| 5 | ZTS |
Zoetis Inc.
|
237,394 | $17,059,132 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
188,565 | $12,058,731 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
690,897 | $11,959,425 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
98,305 | $10,905,956 |
All Filings in BIOA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,091,113 | 62,385 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||